Revival Healthcare Capital led a $90m Series E round in Distalmotion.

Revival Healthcare Capital, an investment company, led a $90m Series E round in Distalmotion, a medical device company. “The market is overdue for a fundamentally new approach to robotic surgery, where the mindset needs to be about ‘the surgeon’s robot,’ not molding ‘the robot’s surgeon. Dexter is designed to work the way surgeons and OR teams work: patient focused and user-centric, providing necessary patient access and optimal tools for every step of the way. We are excited to deliver this powerful value proposition to surgeons, OR teams, and patients worldwide,” Rick Anderson, Revival Chairman.